Jupiter Life Line Hospitals Limited

BSE: 543980 NSE: JLHL
Jupiter Life Line Hospitals Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN L85100MH2002PLC137908 Incorporated 18 November 2002 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - NSE: JLHL · BSE: 543980 Public Limited Company healthcare
Data last updated
Market Cap
₹9,394 Cr
JLHL · NSE
Share Price
₹287.60
+0.37% today
Revenue
₹1,500 Cr
FY 2025-26 · +15.2% YoY
EBITDA
₹338 Cr
Margin 22.6%
Net Profit
₹189 Cr
FY 2025-26 · -0.7% YoY
P/E (TTM)
48.2x
P/B 5.6x
ROE
13.4%
ROCE 15.0%
Debt / Equity
0.34
Interest cover 13.0x

About Jupiter Life Line Hospitals Limited

Data last updated:

Jupiter Life Line Hospitals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the hospital services segment of the healthcare sector. It was incorporated on 18 November 2002 and has been in existence for over 24 years.

Its director Ajay P Thakker and family are #736 among India's richest people (2026).

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L85100MH2002PLC137908. Its GSTIN is 27AABCJ1982E1ZN (Maharashtra). It is a listed company as per MCA records. Its shares are listed on BSE: 543980 and NSE: JLHL.

The company has an authorised share capital of ₹80 Cr and a paid-up capital of ₹65.57 Cr. It is led by directors including Ankit Ajay Thakker (Managing Director) and Ajay Pratap Thakker (Whole-Time Director).

Its last annual general meeting (AGM) was held on 17 July 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 1004 10th Floor 360 Degree Business Park Maharana Pratap Chowk Lbs Marg, Mumbai, Maharashtra, India – 400080.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹1,499.79 Cr, a growth of 15.2% compared to the previous year. For the same year it recorded a net profit of ₹189.4 Cr (net margin 12.6%) and EBITDA of ₹338.38 Cr (EBITDA margin 22.6%). The net worth stands at ₹1,544.09 Cr (up 13.8% YoY). Total assets are valued at ₹2,144.79 Cr (up 21.8% YoY).

The company has about 2,565 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.

The company is associated with 1 brand: Jupiter Hospital. As per MCA filings, the company has open charges of ₹360.9 Cr and satisfied charges of ₹773.74 Cr on record. Court records list 27 cases involving the company, including 22 filed by the company and 5 filed against it; 13 cases are pending. The company has 31 deals on record (12 secondary share transfers, 9 funding rounds, 5 market trades), with disclosed funding of ₹187.13 Cr; the latest was in July 2026. Its 3 peer companies in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (human health activities) are compared by revenue, 2 larger and 1 smaller; the largest is Kovai Medical Center and Hospital Limited with revenue of ₹1,393.22 Cr. The company has 8 MSME Form 1 returns on record between 2021 and 2024, listing 320 overdue payments to 64 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jupiterhospital.com.

Company details

CIN L85100MH2002PLC137908
Registration Number 137908
Incorporation Date 18 November 2002
ROC Mumbai
Listing Status Listed - Listed on NSE (JLHL); Listed on BSE (543980)
Company Status Active
Date of Last AGM 17 July 2026
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant

CIN history

Jupiter Life Line Hospitals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L85100MH2002PLC137908, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L85100MH2002PLC137908Current
U85100MH2002PTC137908Previous
U85100MH2002PLC137908Previous
Key People
Ankit Ajay Thakker Managing Director Ajay Pratap Thakker Whole-Time Director Jasmin A Patel Director

Recognitions & Rankings of Jupiter Life Line Hospitals

Contact details

Jupiter Life Line Hospitals Limited's registered office is in Mumbai, Maharashtra. Its website is jupiterhospital.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    jupiterhospital.com
  • Social Media
  • Registered Address
    1004 10th Floor 360 Degree Business Park Maharana Pratap Chowk Lbs Marg, Mumbai, Maharashtra, India – 400080
  • Industry
    Healthcare, Hospital Services

To see the full contact details of Jupiter Life Line Hospitals Limited, buy the company report.

Comprehensive company report
Jupiter Life Line Hospitals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Jupiter Life Line Hospitals operates one associated brand: Jupiter Hospital. Each brand links to its own profile.

BrandDescriptionWebsite
Jupiter Hospital
Multispecialty hospitals are operated as a chain in India.jupiterhospital.com

Business activity

The main business activities of Jupiter Life Line Hospitals are human health and social work activities and accommodation and food service. In detail, this covers human health activities and food and beverage services provided by hotels, restaurants, caterers, etc.. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHuman health and social work activities86Human health activities
IAccommodation and Food ServiceI2Food and beverage services provided by hotels, restaurants, caterers, etc.

To see the full business activity and turnover split of Jupiter Life Line Hospitals Limited, buy the company report.

Financials of Jupiter Life Line Hospitals Limited

FY 2025-26 filings available

Jupiter Life Line Hospitals Limited reported revenue of ₹1,499.79 Cr (up 15.2% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹1,500 Cr
+15.2% YoY
EBITDA
₹338 Cr
+12.8% YoY
Profit After Tax
₹189 Cr
-0.6% YoY
Net Worth
₹1,544 Cr
+13.8% YoY
Total Assets
₹2,145 Cr
+21.8% YoY
Total Debt
₹584 Cr
+48.6% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,5001,3021,073893733486463
Revenue growth+15.2%+21.3%+20.3%+21.8%+50.8%+5.0%-
EBITDA33830024219915367.1682.60
EBITDA margin+22.6%+23.0%+22.6%+22.3%+20.9%+13.8%+17.8%
Profit before tax26026119512977.091.5532.89
Net profit18919117774.0551.04(2.30)30.90
Net profit margin+12.6%+14.6%+16.5%+8.3%+7.0%-0.5%+6.7%
EPS (₹)29.5929.4726.9412.9010.05(0.45)5.83
Balance sheet
Total assets2,1451,7611,172833784672509
Net worth1,5441,3561,169366294239237
Total debt5843930.00469495426272
Cash & bank58.1794.9830113410319.446.97
Net working capital(9.55)36.1028791.8485.2414.0756.79
Cash flow
Cash from operations26826711517613712374.21
Cash from investing(442)(497)(246)(94.25)(84.27)(295)(43.39)
Cash from financing136297128(51.06)32.20184(31.74)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue456411388365394353337333
Revenue growth (YoY)+16.0%+16.4%+15.2%+9.8%+17.5%+22.3%--
Other income10.5410.5910.669.1311.2712.826.887.21
EBITDA10779.2789.1677.0392.2578.4279.7076.34
EBITDA margin+23.4%+19.3%+23.0%+21.1%+23.4%+22.2%+23.7%+22.9%
Depreciation28.4826.4423.2621.7021.4621.2217.6513.99
Interest13.8312.869.017.557.848.275.612.82
Profit before tax75.0850.5667.5556.9174.2261.7563.3266.74
Tax18.7313.0517.2914.4116.7417.8018.0414.52
Net profit56.3537.5150.2642.5057.4843.9545.2852.22
EPS (₹)1.725.727.666.498.756.696.847.95
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,1981,060915787657461463
Revenue growth+13.0%+15.9%+16.2%+19.8%+42.6%-0.4%-
EBITDA29626922720215969.0882.61
EBITDA margin+24.7%+25.4%+24.9%+25.6%+24.2%+15.0%+17.8%
Profit before tax25724620415910617.5632.90
Net profit18318015210984.4516.6029.64
Net profit margin+15.3%+17.0%+16.6%+13.8%+12.9%+3.6%+6.4%
EPS (₹)29.1928.1723.1818.9716.653.265.83
Balance sheet
Total assets1,9581,5761,247763651514499
Net worth1,6081,4231,245465329253237
Total debt3351420.00298322262263
Cash & bank40.8386.9929713310218.466.96
Net working capital12.7458.6827997.8894.5623.5371.60
Cash flow
Cash from operations23121911018414211374.60
Cash from investing(423)(455)(238)(130)(68.31)(78.22)(43.39)
Cash from financing145302122(23.22)9.66(23.43)(32.14)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue365328312291316278274270
Revenue growth (YoY)+15.5%+18.2%+14.1%+7.8%+14.8%+15.4%--
Other income6.8910.6410.109.1611.3112.847.096.89
Total expenses270259234221237210202202
EBITDA94.1269.1678.1370.0778.8267.5872.0668.68
EBITDA margin+25.8%+21.1%+25.0%+24.0%+25.0%+24.3%+26.3%+25.4%
Depreciation23.4621.5718.4716.8216.6816.6713.3810.64
Interest9.048.124.222.652.963.004.002.65
Profit before tax68.5150.1165.5459.7670.4960.7561.7762.28
Tax17.0612.9316.3415.4915.8817.4617.3412.97

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 07 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue456411388365394353337333
Revenue growth (YoY)+16.0%+16.4%+15.2%+9.8%+17.5%+22.3%--
Other income10.5410.5910.669.1311.2712.826.887.21
EBITDA10779.2789.1677.0392.2578.4279.7076.34
EBITDA margin+23.4%+19.3%+23.0%+21.1%+23.4%+22.2%+23.7%+22.9%
Depreciation28.4826.4423.2621.7021.4621.2217.6513.99
Interest13.8312.869.017.557.848.275.612.82
Profit before tax75.0850.5667.5556.9174.2261.7563.3266.74
Tax18.7313.0517.2914.4116.7417.8018.0414.52
Net profit56.3537.5150.2642.5057.4843.9545.2852.22
EPS (₹)1.725.727.666.498.756.696.847.95
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,5001,3021,073893733486463
Revenue growth+15.2%+21.3%+20.3%+21.8%+50.8%+5.0%-
Other income42.3728.3522.0510.424.024.111.89
Total expenses1,1611,002831693580419380
Employee cost25622519015212910190.11
EBITDA33830024219915367.1682.60
EBITDA margin+22.6%+23.0%+22.6%+22.3%+20.9%+13.8%+17.8%
Depreciation87.6457.0842.3838.5636.1630.7425.91
Interest32.6610.7126.3442.2743.9438.9825.69
Profit before tax26026119512977.091.5532.89
Tax66.2566.9318.8055.8025.993.853.25
Net profit18919117774.0551.04(2.30)30.90
Net profit margin+12.6%+14.6%+16.5%+8.3%+7.0%-0.5%+6.7%
EPS (₹)29.5929.4726.9412.9010.05(0.45)5.83
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital65.5765.5765.5756.5250.8750.8750.87
Reserves & surplus1,4791,2911,103309241188186
Shareholders' funds (net worth)1,5441,3561,169366294239237
Minority interest0.010.06(0.30)(1.78)(5.12)7.470.00
Secured loans5093260.00469486410254
Unsecured loans75.7167.430.000.008.9115.0717.97
Total debt5843930.00469495426272
Total liabilities2,1451,7611,172833784672509
Assets
Gross block1,7811,2901,005965891802576
Net block1,384978718720684630435
Capital work in progress12918574.0029.1526.6225.9110.50
Investments48650717.011.552.887.362.32
Inventories38.3426.4621.3419.0015.3613.0513.97
Sundry debtors75.5443.2357.2145.6927.8721.8444.61
Cash & bank balances58.1794.9830113410319.446.97
Loans & advances27.1620.7713.098.7131.1251.2265.81
Total current assets199185393208178106131
Total current liabilities20914910611692.4891.4874.57
Net working capital(9.55)36.1028791.8485.2414.0756.79
Total assets2,1451,7611,172833784672509
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash92.5226.4026.4810318.466.977.89
Net cash from operating activities26826711517613712374.21
Net cash from investing activities(442)(497)(246)(94.25)(84.27)(295)(43.39)
Net cash from financing activities136297128(51.06)32.20184(31.74)
Net change in cash(37.76)66.11(3.47)31.1084.9012.46(0.92)
Closing cash58.1794.9830113410319.446.97
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+15.2%+21.3%+20.3%+21.8%+50.8%+5.0%-
EBITDA growth+12.8%+24.0%+21.6%+30.0%+128.1%-18.7%-
PBT growth-0.1%+33.4%+51.9%+66.9%+4873.6%-95.3%+9997.0%
Net income growth-0.7%+7.9%+138.5%+45.1%+2319.1%-107.4%-
Revenue CAGR (3Y)+18.9%+21.1%+30.2%+24.5%---
EBITDA CAGR (3Y)+19.3%+25.1%+53.3%+34.1%---
Profitability & leverage
Net income margin+13.0%+14.9%+16.5%+8.2%+7.0%-0.5%+6.4%
Return on capital employed+15.0%+18.5%+22.1%+21.1%+16.7%+6.9%+11.5%
Return on net worth+13.4%+15.3%+23.0%+22.1%+19.2%-1.0%+12.5%
Debt / equity0.340.160.311.461.731.471.15
Long-term debt / equity0.330.150.291.391.661.401.03
Interest cover13.034.4113.1926.3337.55107.0345.32
Efficiency & per share
Fixed asset turnover0.981.131.090.960.870.710.80
Inventory turnover46.2954.4953.2251.9551.6135.9933.14
Debtors turnover25.2625.9320.8624.2729.5014.6310.38
EPS (₹)29.5929.4726.9412.9010.05(0.45)5.83
Dividend per share (₹)1.001.001.000.000.000.000.00
Book value per share (₹)235.50206.85178.3064.7057.3646.9846.54
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue365328312291316278274270
Revenue growth (YoY)+15.5%+18.2%+14.1%+7.8%+14.8%+15.4%--
Other income6.8910.6410.109.1611.3112.847.096.89
Total expenses270259234221237210202202
EBITDA94.1269.1678.1370.0778.8267.5872.0668.68
EBITDA margin+25.8%+21.1%+25.0%+24.0%+25.0%+24.3%+26.3%+25.4%
Depreciation23.4621.5718.4716.8216.6816.6713.3810.64
Interest9.048.124.222.652.963.004.002.65
Profit before tax68.5150.1165.5459.7670.4960.7561.7762.28
Tax17.0612.9316.3415.4915.8817.4617.3412.97
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,1981,060915787657461463
Revenue growth+13.0%+15.9%+16.2%+19.8%+42.6%-0.4%-
Other income42.2528.0725.6913.303.754.031.89
Total expenses902791687585498392380
Employee cost19617715912911410092.75
EBITDA29626922720215969.0882.61
EBITDA margin+24.7%+25.4%+24.9%+25.6%+24.2%+15.0%+17.8%
Depreciation68.6342.4130.5228.6127.6627.3825.91
Interest12.848.6118.6627.7129.2328.1725.69
Profit before tax25724620415910617.5632.90
Tax65.1561.6451.8751.6621.040.963.26
Net profit18318015210984.4516.6029.64
Net profit margin+15.3%+17.0%+16.6%+13.8%+12.9%+3.6%+6.4%
EPS (₹)29.1928.1723.1818.9716.653.265.83
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital65.5765.5765.5756.5250.8750.8750.87
Reserves & surplus1,5421,3571,180409276202186
Shareholders' funds (net worth)1,6081,4231,245465329253237
Secured loans26175.000.00298322262254
Unsecured loans74.0867.430.000.000.000.008.59
Total debt3351420.00298322262263
Total liabilities1,9581,5761,247763651514499
Assets
Gross block1,453977731700660595576
Net block1,123713477476465426435
Capital work in progress11316361.1016.2413.8613.3310.50
Investments58060611195.4470.8665.342.33
Inventories28.5118.1716.7715.4913.3011.5313.97
Sundry debtors67.1437.7846.3540.0327.6520.4344.61
Cash & bank balances40.8386.9929713310218.466.96
Loans & advances49.0732.076.546.6230.4950.7280.63
Total current assets186175367195174101146
Total current liabilities17311688.3197.5779.0477.6174.57
Net working capital12.7458.6827997.8894.5623.5371.60
Total assets1,9581,5761,247763651514499
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash84.5418.9825.3410218.466.967.89
Net cash from operating activities23121911018414211374.60
Net cash from investing activities(423)(455)(238)(130)(68.31)(78.22)(43.39)
Net cash from financing activities145302122(23.22)9.66(23.43)(32.14)
Net change in cash(47.11)65.56(6.36)31.1583.7011.50(0.93)
Closing cash40.8386.9929713310218.466.96
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+13.0%+15.9%+16.2%+19.8%+42.6%-0.4%-
EBITDA growth+9.8%+18.5%+12.6%+27.1%+130.0%-16.4%-
PBT growth+4.1%+20.9%+28.3%+50.3%+502.0%-46.6%+66.7%
Net income growth+1.6%+18.4%+40.0%+28.5%+408.7%-44.0%-
Revenue CAGR (3Y)+15.0%+17.3%+25.6%+19.4%+18.2%+12.9%-
EBITDA CAGR (3Y)+13.6%+19.2%+48.7%+34.7%+34.7%+8.2%-
Profitability & leverage
Net income margin+16.0%+17.4%+16.6%+13.6%+12.9%+3.6%+6.4%
Return on capital employed+15.3%+18.1%+22.1%+26.4%+23.2%+9.0%+12.1%
Return on net worth+12.6%+13.9%+17.8%+27.0%+29.1%+6.8%+13.2%
Debt / equity0.160.050.170.781.001.071.14
Long-term debt / equity0.150.050.170.750.961.021.06
Interest cover5.653.799.4815.9922.2867.5545.31
Efficiency & per share
Fixed asset turnover0.991.241.281.161.050.790.82
Inventory turnover51.3160.6856.7054.6952.9436.1638.29
Debtors turnover22.8325.2021.1823.2727.3414.1813.13
EPS (₹)29.1928.1723.1818.9716.653.265.83
Dividend per share (₹)1.001.001.000.000.000.000.00
Book value per share (₹)245.18216.96189.9282.2864.3049.8046.54

To see the full year-wise statements and ratios of Jupiter Life Line Hospitals Limited, buy the company report.

Board of directors of Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals has 8 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ajay Pratap Thakker
Also directs: Majesty Erectors LLP, Jay Clinic LLP, Western Medical Solutions LLP and 5 more
Whole-Time Director18 Nov 200223 Years 11 MonthsCurrent
Jasmin A Patel
Also directs: Jupiter Hospital Projects Private Limited, MDRC LLP, Mahi Hospitals Private Limited
Director25 Sep 20188 Years 1 MonthsCurrent
Darshan Hiralal VoraDirector25 Sep 20188 Years 1 MonthsCurrent
Vadapatra Sayee Raghavan
Also directs: Jupiter Hospital Projects Private Limited
Director26 Sep 200917 Years 1 MonthsCurrent
Ankit Ajay Thakker
Also directs: Jupiter Hospital Projects Private Limited, Majesty Erectors LLP, Wisdom Village Development LLP and 5 more
Managing Director29 Jun 201610 Years 4 MonthsCurrent
Satish Utekar
Also directs: Steigen Strategies LLP, Steigen Healthcare India Private Limited, Ahmednagar Media and Entertainment Private Limited
Director21 Feb 20233 Years 8 MonthsCurrent
Showing 6 of 8 current directors. View all directors

Peer comparison

Jupiter Life Line Hospitals Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (human health activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Jupiter Life Line Hospitals Limitedthis company₹1,499.79 Cr (FY 2026)₹189.4 Cr12.6%15.2%2,565Mumbai, Maharashtra, India
Kovai Medical Center and Hospital Limited₹1,393.22 Cr (FY 2025)12.0%Coimbatore, Tamil Nadu, India
Indraprastha Medical Corporation Limited₹1,379.01 Cr (FY 2025)9.0%New Delhi, Delhi, India
Shalby Limited₹1,114.55 Cr (FY 2025)17.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Jupiter Life Line Hospitals Limited, buy the company report.

Auditor

Jupiter Life Line Hospitals Limited is audited by ASWIN.P.MALDE & CO. for the financial year 2025.

Auditor firmFinancial yearFirm registration number
ASWIN.P.MALDE & CO.FY 2025100725W

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 40.90%, foreign institutional investors hold 9.40%, domestic institutional investors hold 16.50% and retail and other public shareholders hold 33.20%.

Promoters: 40.90%DII (Domestic Institutional): 16.50%FII (Foreign Institutional): 9.40%Retail & Others: 33.20%
Sep 2026
QUARTER
40.90% Promoters
16.50% DII (Domestic Institutional)
9.40% FII (Foreign Institutional)
33.20% Retail & Others
Promoter holding - history
Now 40.90% · Sep 2026High 40.90% · Dec 2025Low 40.90% · Dec 2025
39%39.8%40.5%41.3%42%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 40.90%Mar 2026: 40.90%Jun 2026: 40.90%Sep 2026: 40.90%40.90%40.90%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters40.90%40.90%40.90%40.90%
Public59.10%59.10%59.10%59.10%

Charges & borrowings

Open charges
₹360.9 Cr
Satisfied charges
₹773.74 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹360.00 Cr
State Bank of India₹0.90 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
24 Mar 2025101085238Hdfc Bank Limited₹360 CrOpen
10 May 2024100925285State Bank of India₹90 LakhOpen
27 Jun 2023100738125Others₹100 CrSatisfied
16 Dec 2021100514645Others₹35 CrSatisfied
16 Dec 2021100514647Others₹20.5 CrSatisfied

To see the full charge records of Jupiter Life Line Hospitals Limited, buy the company report.

Total charge records: 25 View all charges

Deals & funding

Jupiter Life Line Hospitals Limited has 31 deals on record (12 secondary share transfers, 9 funding rounds, 5 market trades), with disclosed funding of ₹187.13 Cr; the latest was in July 2026.

Total deals
31
Secondary share transfers
12
Funding rounds
9
Market trades
5
Rights issues
4
Disclosed funding
₹187.13 Cr

Deals on record (5 of 31)

WhenDealAmountParties
Sep 2023Market trade₹139.21 CrBuyer: NK Securities Research Private Limited , Graviton Research Capital LLP , Elixir Wealth Management Private Limited
Seller: NK Securities Research Private Limited , Graviton Research Capital LLP , Elixir Wealth Management Private Limited
Apr 2023Secondary share transferUndisclosedBuyer: 2 individuals
Seller: Wisdom Wellness Private Limited
Feb 2015Secondary share transferUndisclosedBuyer: Vadapatra Sayee Raghavan HUF, an individual
Seller: Western Medical Solutions LLP
Nov 2014Secondary share transferUndisclosedBuyer: an individual
Seller: Western Medical Solutions LLP
May 2014Secondary share transferUndisclosedBuyer: Wisdom Wellness Private Limited
Seller: an individual

To see the full deal history of Jupiter Life Line Hospitals Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Jupiter Life Line Hospitals Limited was last rated by Care on 28 Feb 2022.

Rating agencyRated onRating
Care28 Feb 2022

To see the full credit ratings and regulatory alerts of Jupiter Life Line Hospitals Limited, buy the company report.

MSME payment delays

Jupiter Life Line Hospitals Limited has 8 MSME Form 1 returns on record between 2021 and 2024, listing 320 overdue payments to 64 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 64)

SupplierAmount dueDue sinceReported on
Associated Therapeutic Care Private Limited
Aadvent
an individual supplier
Medi Pharmaa
SKM Surgicals

To see the full MSME payment records of Jupiter Life Line Hospitals Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Jupiter Life Line Hospitals has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

2
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Jupiter Hospital Projects Private LimitedU74900MP2011PTC054377
Medulla Healthcare Private LimitedU85300MH2022PTC385705

To see the full group structure of Jupiter Life Line Hospitals Limited, buy the company report.

Employees & EPFO

Jupiter Life Line Hospitals Limited has a workforce of 2,565 employees on its EPFO records as of Mar 30, 2024, across 2 active EPFO establishments.

Employee count
2,565
Active EPFO establishments
2
Employee growth
11.04%

GST

Jupiter Life Line Hospitals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AABCJ1982E1ZNMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Jupiter Life Line Hospitals Limited, buy the company report.

Recent activity

Jupiter Life Line Hospitals Limited has 26 board changes on record since 2002: 10 appointments and 16 cessations. The latest: Sivasis Salilkumar Sen was appointed as CFO on 12 May 2025.

AGM
Jupiter Life Line Hospitals Limited last Annual general meeting of members was held on 17 Jul 2026 as per latest MCA records.
Filing
Jupiter Life Line Hospitals Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
Charges
A charge registered on 16 Dec 2021 via Charge ID 100514647 with Others was fully satisfied on 04 Mar 2026.
Charges
A charge registered on 15 Dec 2014 via Charge ID 10539306 with Others was fully satisfied on 22 Dec 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 360.00 Cr registered on 24 Mar 2025 with Charge ID 101085238 was modified on 22 Sep 2025.
Appointed
Sivasis Salilkumar Sen was appointed as CFO.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 360.00 Cr with Charge ID 101085238 was registered on 24 Mar 2025.
Ceased
Amar Harishchandra Manjrekar ceased to be Additional Director.
Appointed
Amar Harishchandra Manjrekar was appointed as Director.
Charges
A charge with State Bank Of India amounted to Rs. 0.90 Cr with Charge ID 100925285 was registered on 10 May 2024.
Charges
A charge registered on 21 May 2021 via Charge ID 100454702 with Others was fully satisfied on 22 Feb 2024.
Charges
A charge registered on 27 Jun 2023 via Charge ID 100738125 with Others was fully satisfied on 05 Oct 2023.

76 earlier events are in the company report.

News

JLHL: Q2 REVENUE 4.56B RUPEES VS 3.94B (YOY)
23 Oct 2026 · Exchange Update
JLHL: Q2 CONS NET PROFIT 562M RUPEES VS 575M (YOY)
23 Oct 2026 · Exchange Update
JLHL: Q2 EBITDA 1.07B RUPEES VS 922M (YOY); Q2 EBITDA MARGIN 23.41% VS 23.44% (YOY)
23 Oct 2026 · Exchange Update
Jupiter Life Line Hospitals: To Hold Analyst And Investor Meeting On September 28 At 1 PM
15 Sep 2026 · Exchange Update

Frequently asked questions

Jupiter Life Line Hospitals is an active public limited company based in Mumbai, Maharashtra, India. The company works in hospital services, within the healthcare industry. It was incorporated on 18 November 2002 (24+ years old) and is registered under CIN L85100MH2002PLC137908. Listed on BSE: 543980 and NSE: JLHL.

Jupiter Life Line Hospitals reported revenue of ₹1,499.79 Cr for FY 2025-26 (up 15.2% YoY) based on consolidated financials.

Jupiter Life Line Hospitals has 8 current directors:

The latest financial statements of Jupiter Life Line Hospitals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 17 July 2026. Year-wise statements from 2015 are in the company report.

The GSTIN of Jupiter Life Line Hospitals is 27AABCJ1982E1ZN, registered in Maharashtra.

The CIN (Corporate Identification Number) of Jupiter Life Line Hospitals is L85100MH2002PLC137908. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Jupiter Life Line Hospitals is a listed company as per MCA records. Its shares are listed on both BSE (code: 543980) and NSE (symbol: JLHL).

Jupiter Life Line Hospitals has 27 court cases on record: 22 filed by the company and 5 filed against it. 13 are pending. Most are in the high courts.

Jupiter Life Line Hospitals was incorporated on 18 November 2002, making it 24+ years old. It is registered with the Registrar of Companies, Mumbai.

Jupiter Life Line Hospitals has 31 deals on record (12 secondary share transfers, 9 funding rounds, 5 market trades), with disclosed funding of ₹187.13 Cr; the latest was in July 2026.

The peers of Jupiter Life Line Hospitals by revenue are Kovai Medical Center and Hospital Limited, Indraprastha Medical Corporation Limited, Shalby Limited, all in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (human health activities).

Sivasis Salilkumar Sen was appointed as CFO on 12 May 2025. Amar Harishchandra Manjrekar ceased to be Additional Director on 26 Oct 2024. Amar Harishchandra Manjrekar was appointed as Director on 09 Aug 2024. Jupiter Life Line Hospitals has 26 board changes on record in total.